Kelyniam Global, Inc. (KLYG)
USD 0.22
(22.22%)
USD 0.22
(22.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.03 Million USD | -7.28% |
| 2022 | 2.19 Million USD | 7.41% |
| 2021 | 2.04 Million USD | 74.72% |
| 2020 | 1.17 Million USD | 8.98% |
| 2019 | 1.07 Million USD | -7.12% |
| 2018 | 1.15 Million USD | 5.99% |
| 2017 | 1.09 Million USD | 37.92% |
| 2016 | 790.88 Thousand USD | 0.41% |
| 2015 | 787.67 Thousand USD | -14.0% |
| 2014 | 915.94 Thousand USD | 6.15% |
| 2013 | 862.84 Thousand USD | 0.0% |
| 2007 | 46.56 Thousand USD | -32.76% |
| 2006 | 69.25 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 735.98 Thousand USD | 1.84% |
| 2024 Q2 | 564.51 Thousand USD | -23.3% |
| 2023 Q1 | 467.56 Thousand USD | -27.0% |
| 2023 FY | 1.99 Million USD | -9.17% |
| 2023 Q2 | 394.36 Thousand USD | -15.66% |
| 2023 Q3 | 400.94 Thousand USD | 1.67% |
| 2023 Q4 | 722.66 Thousand USD | 80.24% |
| 2022 Q4 | 640.54 Thousand USD | 27.75% |
| 2022 Q2 | 552.68 Thousand USD | 9.29% |
| 2022 Q1 | 505.68 Thousand USD | -9.85% |
| 2022 FY | 2.19 Million USD | 7.41% |
| 2022 Q3 | 501.41 Thousand USD | -9.28% |
| 2021 FY | 2.04 Million USD | 74.72% |
| 2021 Q2 | 435.65 Thousand USD | -13.19% |
| 2021 Q3 | 546.11 Thousand USD | 25.36% |
| 2021 Q1 | 501.83 Thousand USD | 128.0% |
| 2021 Q4 | 560.92 Thousand USD | 2.71% |
| 2020 Q1 | 314.97 Thousand USD | 1.09% |
| 2020 Q4 | 220.1 Thousand USD | -30.13% |
| 2020 FY | 1.17 Million USD | 8.98% |
| 2020 Q3 | 315 Thousand USD | 10.07% |
| 2020 Q2 | 286.19 Thousand USD | -9.14% |
| 2019 Q2 | 145.25 Thousand USD | -51.25% |
| 2019 FY | 1.07 Million USD | -7.12% |
| 2019 Q4 | 311.59 Thousand USD | 6.17% |
| 2019 Q1 | 297.98 Thousand USD | 0.0% |
| 2019 Q3 | 293.49 Thousand USD | 102.05% |
| 2018 FY | 1.15 Million USD | 5.99% |
| 2017 FY | 1.09 Million USD | 37.92% |
| 2016 FY | 790.88 Thousand USD | 0.41% |
| 2015 FY | 787.67 Thousand USD | -14.0% |
| 2014 Q1 | 269.78 Thousand USD | 0.0% |
| 2014 FY | 915.94 Thousand USD | 6.15% |
| 2014 Q3 | 282.72 Thousand USD | 0.0% |
| 2014 Q4 | 140.7 Thousand USD | -50.23% |
| 2013 Q2 | 233.42 Thousand USD | 1.92% |
| 2013 Q1 | 229.02 Thousand USD | 0.0% |
| 2013 FY | 862.84 Thousand USD | 0.0% |
| 2008 Q1 | 5450.00 USD | -16.15% |
| 2007 Q1 | 24.45 Thousand USD | 0.0% |
| 2007 Q4 | 6500.00 USD | 4.08% |
| 2007 Q3 | 6245.00 USD | -33.32% |
| 2007 FY | 46.56 Thousand USD | -32.76% |
| 2007 Q2 | 9366.00 USD | -61.7% |
| 2006 FY | 69.25 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | -336.563% |
| IR-Med Inc. | -17 Thousand USD | 12076.929% |
| Polarean Imaging plc | 335.48 Thousand USD | -506.909% |
| Medical Supply International USA, Inc. | 1.75 Million USD | -15.773% |
| Avitar, Inc. | 836.7 Thousand USD | -143.346% |
| AVITA Medical, Inc. | 41.68 Million USD | 95.116% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 203707.8% |
| Össur hf. | 485.57 Million USD | 99.581% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 1142.427% |
| QHSLab, Inc. | 793.6 Thousand USD | -156.56% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | 99.581% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 87.84% |
| Escalon Medical Corp. | 5.14 Million USD | 60.435% |
| Aurora Spine Corporation | 8.21 Million USD | 75.204% |
| BrainsWay Ltd. | 23.09 Million USD | 91.182% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 105.1 Thousand USD | -1837.222% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 94.196% |
| Vivos Inc. | -6036.00 USD | 33832.24% |
| MicroPort Scientific Corporation | 532.09 Million USD | 99.617% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 369.059% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -3497.692% |
| Nanomix Corporation | -69.45 Thousand USD | 3031.38% |
| Theraclion SA | -1.08 Million USD | 288.459% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | -246.537% |
| Positron Corporation | -353.46 Thousand USD | 676.034% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | -94.746% |
| Lombard Medical, Inc. | 955 Thousand USD | -113.202% |
| ALR Technologies Inc. | 4945.00 USD | -41074.479% |
| Stratec SE | 71.58 Million USD | 97.156% |
| Vycor Medical, Inc. | 1.31 Million USD | -54.758% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 15883.55% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -886.381% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 85.824% |
| VMS Rehab Systems, Inc. | -10.44 USD | 19502762.835% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -5555.772% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -658.096% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | -8000.00 USD | 25550.975% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | -86.105% |
| Urologix, Inc. | 6.09 Million USD | 66.583% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 742.923% |
| SS Innovations International, Inc. | 713.44 Thousand USD | -185.386% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 99.948% |
| NIOX Group Plc | 28.13 Million USD | 92.763% |
| Fuse Medical, Inc. | 10.73 Million USD | 81.031% |
| Broncus Holding Corporation | 7.22 Million USD | 71.827% |
| Brain Scientific Inc. | 54.32 Thousand USD | -3647.958% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | -154.649% |
| Health Logic Interactive Inc. | - USD | -Infinity% |